share_log

三葉草生物-B：(經修訂) 截至2024年5月31日止月份股份發行人的證券變動月報表

CLOVER BIO-B: (Revised) Monthly Return of Equity Issuer on Movements in Securities for the Month ended May 31, 2024

Hong Kong Stock Exchange ·  Jul 17 22:03
Summary by Futu AI
三葉草生物製藥有限公司（「本公司」）於2024年7月17日重新提交了截至2024年5月31日的證券變動月報表。報告顯示，公司的法定/註冊股本及已發行股份（不包括庫存股份）在報告期間內均無變動，維持在2,000,000,000股普通股，面值0.0001美元，總額200,000美元；已發行股份總數為1,297,047,429股。此外，公司的股份期權計劃中，首次公開發售前後購股權計劃的股份期權數目亦無增減，分別維持在1,854,317股及37,925,004股。報告期內，沒有行使股份期權發行新股或轉讓庫存股份，且無期權失效。本公司確認所有證券發行或庫存股份出售或轉讓均已獲董事會授權並遵守相關規定。
三葉草生物製藥有限公司（「本公司」）於2024年7月17日重新提交了截至2024年5月31日的證券變動月報表。報告顯示，公司的法定/註冊股本及已發行股份（不包括庫存股份）在報告期間內均無變動，維持在2,000,000,000股普通股，面值0.0001美元，總額200,000美元；已發行股份總數為1,297,047,429股。此外，公司的股份期權計劃中，首次公開發售前後購股權計劃的股份期權數目亦無增減，分別維持在1,854,317股及37,925,004股。報告期內，沒有行使股份期權發行新股或轉讓庫存股份，且無期權失效。本公司確認所有證券發行或庫存股份出售或轉讓均已獲董事會授權並遵守相關規定。
On July 17th, 2024, Three Leaves Biopharmaceutical Co., Ltd. ("the Company") resubmitted the securities change monthly report for the period ending on May 31st, 2024. The report shows that the Company's statutory/registered share capital and issued shares (excluding treasury shares) remained unchanged during the reporting period, maintaining at 2,000,000,000 ordinary shares with a par value of $0.0001 per share, with a total value of $200,000; the total number of issued shares is 1,297,047,429 shares. In addition, there was no change in the number of share options in the Company's share option plan before and after the initial public offering, with 1,854,317 shares and 37,925,004 shares respectively. During the reporting period, no stock options were exercised for the issue of new shares or the transfer of treasury shares, and no options expired. The Company confirms that all securities issuance or treasury shares sale or transfer have been authorized by the board of directors and comply with relevant regulations.
On July 17th, 2024, Three Leaves Biopharmaceutical Co., Ltd. ("the Company") resubmitted the securities change monthly report for the period ending on May 31st, 2024. The report shows that the Company's statutory/registered share capital and issued shares (excluding treasury shares) remained unchanged during the reporting period, maintaining at 2,000,000,000 ordinary shares with a par value of $0.0001 per share, with a total value of $200,000; the total number of issued shares is 1,297,047,429 shares. In addition, there was no change in the number of share options in the Company's share option plan before and after the initial public offering, with 1,854,317 shares and 37,925,004 shares respectively. During the reporting period, no stock options were exercised for the issue of new shares or the transfer of treasury shares, and no options expired. The Company confirms that all securities issuance or treasury shares sale or transfer have been authorized by the board of directors and comply with relevant regulations.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.